Literature DB >> 26838136

Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres.

A Talaminos1, L López-Cerero2, J Calvillo1, A Pascual2, L M Roa1, J Rodríguez-Baño2.   

Abstract

ST131 Escherichia coli is an emergent clonal group that has achieved successful worldwide spread through a combination of virulence and antimicrobial resistance. Our aim was to develop a mathematical model, based on current knowledge of the epidemiology of ESBL-producing and non-ESBL-producing ST131 E. coli, to provide a framework enabling a better understanding of its spread within the community, in hospitals and long-term care facilities, and the potential impact of specific interventions on the rates of infection. A model belonging to the SEIS (Susceptible-Exposed-Infected-Susceptible) class of compartmental models, with specific modifications, was developed. Quantification of the model is based on the law of mass preservation, which helps determine the relationships between flows of individuals and different compartments. Quantification is deterministic or probabilistic depending on subpopulation size. The assumptions for the model are based on several developed epidemiological studies. Based on the assumptions of the model, an intervention capable of sustaining a 25% reduction in person-to-person transmission shows a significant reduction in the rate of infections caused by ST131; the impact is higher for non-ESBL-producing ST131 isolates than for ESBL producers. On the other hand, an isolated intervention reducing exposure to antimicrobial agents has much more limited impact on the rate of ST131 infection. Our results suggest that interventions achieving a continuous reduction in the transmission of ST131 in households, nursing homes and hospitals offer the best chance of reducing the burden of the infections caused by these isolates.

Entities:  

Keywords:  Epidemiology; Escherichia coli; ST131; extended-spectrum β-lactamases; mathematical model; transmission

Mesh:

Year:  2016        PMID: 26838136      PMCID: PMC9150611          DOI: 10.1017/S0950268816000030

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  28 in total

1.  An intuitive formulation for the reproductive number for the spread of diseases in heterogeneous populations.

Authors:  J M Hyman; J Li
Journal:  Math Biosci       Date:  2000-09       Impact factor: 2.144

Review 2.  Large-scale spatial-transmission models of infectious disease.

Authors:  Steven Riley
Journal:  Science       Date:  2007-06-01       Impact factor: 47.728

3.  Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications.

Authors:  Lorena López-Cerero; María Dolores Navarro; Mar Bellido; Almudena Martín-Peña; Laura Viñas; José Miguel Cisneros; Sara Louise Gómez-Langley; Herminia Sánchez-Monteseirín; Isabel Morales; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  J Antimicrob Chemother       Date:  2013-10-11       Impact factor: 5.790

4.  Risk factors for household transmission of community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Jessica M Nerby; Rachel Gorwitz; Lindsey Lesher; Billie Juni; Selina Jawahir; Ruth Lynfield; Kathleen Harriman
Journal:  Pediatr Infect Dis J       Date:  2011-11       Impact factor: 2.129

Review 5.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

6.  Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK.

Authors:  Hiran Dhanji; Niamh M Murphy; Michel Doumith; Sema Durmus; Susanne Surman Lee; Russell Hope; Neil Woodford; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2010-10-01       Impact factor: 5.790

7.  Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.

Authors:  Jesús Rodríguez-Baño; Lorena López-Cerero; María D Navarro; Paula Díaz de Alba; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2008-07-18       Impact factor: 5.790

8.  Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance.

Authors:  Lorena López-Cerero; María del Mar Bellido; Lara Serrano; Julia Liró; Jose Miguel Cisneros; Jesús Rodríguez-Baño; Alvaro Pascual
Journal:  Enferm Infecc Microbiol Clin       Date:  2012-11-20       Impact factor: 1.731

9.  Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.

Authors:  James R Johnson; Marie-Hélène Nicolas-Chanoine; Chitrita DebRoy; Mariana Castanheira; Ari Robicsek; Glen Hansen; Scott Weissman; Carl Urban; Joanne Platell; Darren Trott; George Zhanel; Connie Clabots; Brian D Johnston; Michael A Kuskowski
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

Review 10.  Modelling the transmission of healthcare associated infections: a systematic review.

Authors:  Esther van Kleef; Julie V Robotham; Mark Jit; Sarah R Deeny; William J Edmunds
Journal:  BMC Infect Dis       Date:  2013-06-28       Impact factor: 3.090

View more
  7 in total

Review 1.  Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options.

Authors:  Gisele Peirano; Johann D D Pitout
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

2.  Examining the role of person-to-person transmission during a verocytotoxigenic Escherichia coli outbreak in Ontario, Canada.

Authors:  Roksolana Hovdey; Jan M Sargeant; David N Fisman; Amy L Greer
Journal:  BMC Res Notes       Date:  2022-05-21

3.  Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review.

Authors:  D E Ramsay; J Invik; S L Checkley; S P Gow; N D Osgood; C L Waldner
Journal:  Epidemiol Infect       Date:  2018-07-31       Impact factor: 4.434

4.  Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs.

Authors:  Josie Hughes; Xi Huo; Lindsey Falk; Amy Hurford; Kunquan Lan; Bryan Coburn; Andrew Morris; Jianhong Wu
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

5.  Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence.

Authors:  Isabel Morales Barroso; Lorena López-Cerero; María Dolores Navarro; Belén Gutiérrez-Gutiérrez; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-15       Impact factor: 4.887

6.  Population-level mathematical modeling of antimicrobial resistance: a systematic review.

Authors:  Anna Maria Niewiadomska; Bamini Jayabalasingham; Jessica C Seidman; Lander Willem; Bryan Grenfell; David Spiro; Cecile Viboud
Journal:  BMC Med       Date:  2019-04-24       Impact factor: 8.775

7.  Transmission of gram-negative antibiotic-resistant bacteria following differing exposure to antibiotic-resistance reservoirs in a rural community: a modelling study for bloodstream infections.

Authors:  Eduardo A Undurraga; Jasmina Panovska-Griffiths; Kasim Allel; Lara Goscé; Rafael Araos; Daniel Toro; Catterina Ferreccio; Jose M Munita
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.